BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 26656780)

  • 1. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.
    Hawkins NA; Kearney JA
    Epilepsy Res; 2016 Jan; 119():20-3. PubMed ID: 26656780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
    Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
    Epilepsia; 2016 Jun; 57(6):e103-7. PubMed ID: 27112236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-Seq.
    Hawkins NA; Kearney JA
    Genes Brain Behav; 2012 Jun; 11(4):452-60. PubMed ID: 22471526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKII modulates sodium current in neurons from epileptic
    Thompson CH; Hawkins NA; Kearney JA; George AL
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1696-1701. PubMed ID: 28137877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
    Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
    Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.
    Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
    Epilepsia; 2017 Aug; 58(8):e111-e115. PubMed ID: 28556246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
    Kearney JA; Yang Y; Beyer B; Bergren SK; Claes L; Dejonghe P; Frankel WN
    Hum Mol Genet; 2006 Mar; 15(6):1043-8. PubMed ID: 16464983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.
    Bergren SK; Rutter ED; Kearney JA
    Mamm Genome; 2009 Jun; 20(6):359-66. PubMed ID: 19513789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
    Miller AR; Hawkins NA; McCollom CE; Kearney JA
    Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a.
    Bergren SK; Chen S; Galecki A; Kearney JA
    Mamm Genome; 2005 Sep; 16(9):683-90. PubMed ID: 16245025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.
    Jorge BS; Campbell CM; Miller AR; Rutter ED; Gurnett CA; Vanoye CG; George AL; Kearney JA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5443-8. PubMed ID: 21402906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
    Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
    Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.
    Kearney JA; Copeland-Hardin LD; Duarte S; Zachwieja NA; Eckart-Frank IK; Hawkins NA
    Mamm Genome; 2022 Dec; 33(4):565-574. PubMed ID: 35606653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.
    Kearney JA; Plummer NW; Smith MR; Kapur J; Cummins TR; Waxman SG; Goldin AL; Meisler MH
    Neuroscience; 2001; 102(2):307-17. PubMed ID: 11166117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
    Niibori Y; Lee SJ; Minassian BA; Hampson DR
    Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scn1a dysfunction alters behavior but not the effect of stress on seizure response.
    Sawyer NT; Helvig AW; Makinson CD; Decker MJ; Neigh GN; Escayg A
    Genes Brain Behav; 2016 Mar; 15(3):335-47. PubMed ID: 26694226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.